Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Nutr ESPEN ; 29: 72-76, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30661704

RESUMO

BACKGROUND & AIMS: Patients in the intensive care unit are experiencing an increased malnutrition risk. The NUTrition Risk in the Critically ill score (NUTRIC) is a validated tool for the identification of patients that will benefit the most, from nutritional intervention. The aim of the study was twofold, including: 1) to translate and adapt the NUTRIC score in the Greek language for more efficient and comprehensive use among clinicians, and 2) to assess its prognostic performance in a pilot sample. METHODS: The translation process followed standardized steps: 1) initial translation, 2) synthesis of different translations, 3) back -translation to the English language, 4) revision and cultural adaptation of the instrument by an expert committee. A pilot application study was conducted on 80 critically ill patients from three ICUs in Greek hospitals. The NUTRIC score was calculated using the final translated version. RESULTS: The translated score was considered easy to use, fast and comprehensive. No specific corrections were suggested by the expert committee. According to the translated version of the score 56% of the screened patients were classified as of high nutritional risk (score between 5 and 9). Compared to the low - NUTRIC patients, high - NUTRIC patients were older (56.4 ± 16.4 vs. 68.7 ± 12.7 yrs, p < 0.001), had increased APACHE (13.8 ± 6.5 vs. 23.8 ± 6.5, p < 0.001) and SOFA scores (4.7 ± 3.1 vs. 10.4 ± 3.1, p < 0.001) and demonstrated more comorbidities. Elevated 28 -day mortality was observed among high -NUTRIC patients compared to the low - NUTRIC ones (6 vs. 18 patients, p < 0.05). CONCLUSIONS: The Greek version of the NUTRIC score is ready for use among health care professionals employed in intensive care units in Greek speaking countries, aiming to discriminate critically ill patients benefiting from enhanced nutritional support.


Assuntos
Estado Terminal/mortalidade , Unidades de Terapia Intensiva , Desnutrição/complicações , Estado Nutricional , Traduções , APACHE , Adulto , Idoso , Idoso de 80 Anos ou mais , Comorbidade , Feminino , Grécia , Mortalidade Hospitalar , Humanos , Idioma , Masculino , Pessoa de Meia-Idade , Apoio Nutricional , Escores de Disfunção Orgânica , Medição de Risco , Inquéritos e Questionários
2.
Acta Paediatr ; 106(5): 721-726, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28173607

RESUMO

For years, the advice was to postpone introducing allergenic foods, in order to prevent food allergies. However, food allergies have escalated rather than declined and our review of the latest epidemiological, immunological and nutritional research suggests that early weaning practices may be beneficial. The most allergenic foods, such as fish, eggs and peanuts, have proved to be inherently rich in tolerogenic substances that can play a significant role in preventing allergies. CONCLUSION: We found evidence that the immunoregulatory and anti-inflammatory properties of allergenic foods can provoke oral tolerance if introduced early to both low-risk and high-risk infants.


Assuntos
Hipersensibilidade a Ovo/imunologia , Tolerância Imunológica , Hipersensibilidade a Amendoim/imunologia , Desmame , Hipersensibilidade a Ovo/prevenção & controle , Humanos , Lactente , Hipersensibilidade a Amendoim/prevenção & controle
3.
Eur J Intern Med ; 20(7): 663-71, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19818284

RESUMO

Angiogenesis is the physiological process of the formation of new blood vessels from pre-existing ones. Multiple molecules regulate angiogenesis, such as the vascular endothelial growth factor, angiopoietins, the fibroblast growth factor, the platelet-derived growth factor and the transforming growth factor-beta. Angiogenesis plays an important role in the growth, progression and metastasis of a tumour. Inhibiting the angiogenic process or targeting existing tumour vessels can be used for treatment of tumours as an alternative or in parallel with conventional chemotherapy. Many anti-angiogenic factors are under investigation and some are already being used in clinical practice with various results.


Assuntos
Inibidores da Angiogênese/uso terapêutico , Neoplasias , Neovascularização Patológica/tratamento farmacológico , Neovascularização Patológica/fisiopatologia , Humanos , Neoplasias/irrigação sanguínea , Neoplasias/tratamento farmacológico , Neoplasias/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...